Speaker illustration

Doctor Yoshiyuki Morishima

Daiichi Sankyo Co., Ltd., Tokyo (Japan)

A direct thrombin inhibitor paradoxically enhances thrombin generation via suppression of protein C activation and factor Va degradation in human plasma

Event: ESC CONGRESS 2016

Topic: Endothelial function

Session: Vascular biology

Thumbnail

This platform is supported by

logo Novo Nordisk